Contact Information
Company Information
Company
Renibus Therapeutics Inc
Total Funding
177199437.0
Technologies
Outlook
Gravity Forms
WordPress.org
Google Font API
Mobile Friendly
Remote
AI
Keywords
biotechnology research
cardiovascular
renal
metabolic diseases
biopharmaceuticals
clinical trials
disease prevention
outcome improvement
organ protection
fda breakthrough designation
phase 3 trials
rbt-1
preconditioning agent
stannic protoporphyrin
iron sucrose
iv drug administration
post-operative complications
cardiac surgery
valve surgery
veverimer
hydrochloric acid binder
orphan diseases
non-absorbed medication
phase 2 trials
fast track designation
cytoprotective mechanisms
biotech innovations
patient care
gastrointestinal benefits
disease progression
clinical efficacy
treatment paradigms
surgical outcomes
patient safety
hospital stay reduction
iron therapy
acute kidney injury
research publications
investor relations
healthcare conferences
clinical development
drug approval process
pharmaceutical research
medical advancements
therapeutic candidates
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans